Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 210 results:
Συντάκτης Τίτλος [ Τύπος(Asc)] Έτος
Φίλτρα: Συντάκτης is Athyros, Vasilios G  [Clear All Filters]
Journal Article
Athyros, V. G., Hatzitolios A. I., Karagiannis A., Savopoulos C., Katsiki N., Tziomalos K., et al. (2011).  IMproving the imPlemEntation of cuRrent guidelines for the mAnagement of major coronary hearT disease rIsk factors by multifactorial interVEntion. The IMPERATIVE renal analysis.. Arch Med Sci. 7(6), 984-92.
Karagiannis, A., Hatzitolios A. I., Athyros V. G., Deligianni K., Charalambous C., Papathanakis C., et al. (2009).  Implementation of guidelines for the management of arterial hypertension. The impulsion study.. Open Cardiovasc Med J. 3, 26-34.
Anagnostis, P., Athyros V. G., Karagiannis A., & Mikhailidis D. P. (2011).  Impact of statins on glucose metabolism--a matter of debate.. Am J Cardiol. 107(12), 1866.
Athyros, V. G., Tziomalos K., Katsiki N., Gossios T. D., Giouleme O., Anagnostis P., et al. (2013).  The impact of smoking on cardiovascular outcomes and comorbidities in statin-treated patients with coronary artery disease: a post hoc analysis of the GREACE study.. Curr Vasc Pharmacol. 11(5), 779-84.
Athyros, V. G., Mitsiou E. K., Tziomalos K., Karagiannis A., & Mikhailidis D. P. (2010).  Impact of managing atherogenic dyslipidemia on cardiovascular outcome across different stages of diabetic nephropathy.. Expert Opin Pharmacother. 11(5), 723-30.
Athyros, V. G., Mikhailidis D. P., Kakafika A. I., Karagiannis A., Hatzitolios A., Tziomalos K., et al. (2007).  Identifying and attaining LDL-C goals: mission accomplished? Next target: new therapeutic options to raise HDL-C levels.. Curr Drug Targets. 8(3), 483-8.
Katsiki, N., Doumas M., Athyros V. G., & Karagiannis A. (2015).  Hyperuricemia as a risk factor for cardiovascular disease.. Expert Rev Cardiovasc Ther. 13(1), 19-20.
Katsiki, N., Athyros V. G., Karagiannis A., & Mikhailidis D. P. (2011).  Hyperuricaemia and non-alcoholic fatty liver disease (NAFLD): a relationship with implications for vascular risk?. Curr Vasc Pharmacol. 9(6), 698-705.
Athyros, V. G., Katsiki N., Karagiannis A., & Mikhailidis D. P. (2015).  High-intensity statin therapy and regression of coronary atherosclerosis in patients with diabetes mellitus.. J Diabetes Complications. 29(1), 142-5.
Athyros, V. G., & Mikhailidis D. P. (2016).  High incidence of metabolic syndrome further increases cardiovascular risk in patients with type 2 diabetes. Implications for everyday practice.. J Diabetes Complications. 30(1), 9-11.
Kakafika, A., Athyros V. G., Tziomalos K., Karagiannis A., & Mikhailidis D. P. (2008).  High density lipoprotein cholesterol and statin trials.. Curr Med Chem. 15(22), 2265-70.
Karagiannis, A., Mikhailidis D. P., Tziomalos K., Kakafika A. I., & Athyros V. G. (2008).  Has the time come for a new definition of microalbuminuria?. Curr Vasc Pharmacol. 6(2), 81-3.
Athyros, V. G., Tziomalos K., Karagiannis A., & Mikhailidis D. P. (2015).  Genetic, epidemiologic and clinical data strongly suggest that fasting or non-fasting triglycerides are independent cardiovascular risk factors.. Curr Med Res Opin. 31(3), 435-8.
Katsiki, N., Athyros V. G., Karagiannis A., & Mikhailidis D. P. (2012).  Fibrinogen, hematocrit, and platelets in mild kidney dysfunction and the role of uric acid: an Italian male population study.. Clin Appl Thromb Hemost. 18(1), 113-4.
Katsiki, N., Athyros V. G., & Karagiannis A. (2016).  Exploring the Management of Statin Intolerant Patients: 2016 and Beyond.. Curr Vasc Pharmacol. 14(6), 523-533.
Daskalopoulos, G., Karkanaki A., Piouka A., Prapas N., Panidis D., Gkeleris P., et al. (2015).  Excess Metabolic and Cardiovascular Risk is not Manifested in all Phenotypes of Polycystic Ovary Syndrome: Implications for Diagnosis and Treatment.. Curr Vasc Pharmacol. 13(6), 788-800.
Kostapanos, M. S., Athyros V. G., Mikhailidis D. P., & Elisaf M. S. (2013).  Evaluation of the incidence and risk factors for development of fenofibrate-associated nephrotoxicity.. J Clin Lipidol. 7(1), 88.
Tziomalos, K., Athyros V. G., Karagiannis A., & Mikhailidis D. P. (2008).  Established and emerging vascular risk factors and the development of aortic stenosis: an opportunity for prevention?. Expert Opin Ther Targets. 12(7), 809-20.
Tziomalos, K., Athyros V. G., Karagiannis A., & Mikhailidis D. P. (2007).  Endothelial function, arterial stiffness and lipid lowering drugs.. Expert Opin Ther Targets. 11(9), 1143-60.
Anagnostis, P., Karagiannis A., Tziomalos K., Athyros V. G., Kita M., & Mikhailidis D. P. (2010).  Endocrine hypertension: diagnosis and management of a complex clinical entity.. Curr Vasc Pharmacol. 8(5), 646-60.
Katsiki, N., Athyros V. G., Karagiannis A., & Mikhailidis D. P. (2012).  Efficacy and tolerability of once-weekly rosuvastatin in patients with previous statin intolerance.. J Clin Lipidol. 6(1), 93.
Anagnostis, P., Vaitsi K., Kleitsioti P., Mantsiou C., Pavlogiannis K., Athyros V. G., et al. (2020).  Efficacy and safety of statin use in children and adolescents with familial hypercholesterolaemia: a systematic review and meta-analysis of randomized-controlled trials.. Endocrine.
Athyros, V. G., Kakafika A. I., Papageorgiou A. A., Paraskevas K. I., Tziomalos K., Anagnostis P., et al. (2008).  Effects of statin treatment in men and women with stable coronary heart disease: a subgroup analysis of the GREACE Study.. Curr Med Res Opin. 24(6), 1593-9.
Athyros, V. G., Kakafika A. I., Karagiannis A., Koragiannis A., Mikhailidis D. P., & Mikhalidis D. P. (2008).  Effects of simvastatin alone versus fenofibrate alone versus simvastatin plus fenofibrate on lipoprotein subparticle profiles in patients with diabetes mellitus and mixed dyslipidemia.. Am J Cardiol. 101(11), 1679-80.
Koumaras, C., Tziomalos K., Stavrinou E., Katsiki N., Athyros V. G., Mikhailidis D. P., et al. (2014).  Effects of renin-angiotensin-aldosterone system inhibitors and beta-blockers on markers of arterial stiffness.. J Am Soc Hypertens. 8(2), 74-82.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές